Skip to content
Screener

AtriCure ATRC Operating Income

Discontinued — last reported Q2 '26

Operating Income at other companies

Abbott logo
AbbottABT
$1.69B-17.5%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$7.14B+7.4%
Boston Scientific logo
Boston ScientificBSX
$1.18B+43.8%
Medtronic logo
MedtronicMDT
$1.87B+30.4%
ITG
Integer HoldingsITGR
$31.87M-35.7%
AngioDynamics logo
AngioDynamicsANGO
-$10.2M-76.1%

Other financials

Income statement

See full
Revenue$153.6M+12.8%
Gross profit$118.6M+16.9%
Net income$9.0M+245%
EPS (diluted)$0.18+238%

Balance sheet

See full
Cash & equivalents$167.8M+42.4%
Total debt$75.5M-3.8%
Total equity$516.4M+11.2%
Total assets$676.6M+11.1%

Cash flow

See full
Operating cash flow$22.2M+2.7%
CapEx$3.8M+41.5%
Free cash flow$18.4M-2.8%

Valuation

See full
Market cap$2.01B+10.7%
Enterprise value$1.92B+7.9%
P/E770.8×
P/S3.5×-0.1×

Profitability

See full
Gross margin76.3%+1.6pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.3%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.1×0.0×
Current ratio4.2×+0.3×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: AtriCure’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 1:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001323885-26-000035
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Research and development expenses26,40229,28450,63751,812
Selling, general and administrative expenses82,56278,390167,112154,444
Total operating expenses108,964107,674217,749206,256
Income (loss) from operations9,665(6,192)10,191(12,146)
Other income (expense):
Interest expense(1,318)(1,490)(2,658)(2,906)
Interest income1,1799412,4241,983
Other income (expense)(100)812(137)632

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is AtriCure's operating income?
AtriCure (ATRC) reported operating income of $9.67M in Q2 2026.
How has AtriCure's operating income changed year-over-year?
AtriCure's operating income increased by 256.1% year-over-year, from -$6.19M to $9.67M.
What is the long-term trend for AtriCure's operating income?
Over 2 years (2022 to 2024), AtriCure's operating income has grown at a -3.2% compound annual growth rate (CAGR), from -$42.67M to -$40.01M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about AtriCure's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude